Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Dystrophin Market Growth 2022-2028

  • LP 4793428
  • 97 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Dystrophin will have significant change from previous year. According to our (LP Information) latest study, the global Dystrophin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Dystrophin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Dystrophin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dystrophin market, reaching US$ million by the year 2028. As for the Europe Dystrophin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Dystrophin players cover Asklepios BioPharmaceutical Inc, BioMarin Pharmaceutical Inc, Daiichi Sankyo Company Ltd, and Editas Medicine Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Dystrophin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

DS-5141

Biostrophin

BMBD-001

NS-065

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Genetic Disorders

Musculoskeletal Disorders

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Asklepios BioPharmaceutical Inc

BioMarin Pharmaceutical Inc

Daiichi Sankyo Company Ltd

Editas Medicine Inc

Genethon SA

Nippon Shinyaku Co Ltd

Pfizer Inc

Sarepta Therapeutics Inc

WAVE Life Sciences Ltd

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dystrophin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Dystrophin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Dystrophin by Country/Region, 2017, 2022 & 2028

2.2 Dystrophin Segment by Type

2.2.1 DS-5141

2.2.2 Biostrophin

2.2.3 BMBD-001

2.2.4 NS-065

2.2.5 Others

2.3 Dystrophin Sales by Type

2.3.1 Global Dystrophin Sales Market Share by Type (2017-2022)

2.3.2 Global Dystrophin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Dystrophin Sale Price by Type (2017-2022)

2.4 Dystrophin Segment by Application

2.4.1 Genetic Disorders

2.4.2 Musculoskeletal Disorders

2.4.3 Others

2.5 Dystrophin Sales by Application

2.5.1 Global Dystrophin Sale Market Share by Application (2017-2022)

2.5.2 Global Dystrophin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Dystrophin Sale Price by Application (2017-2022)

3 Global Dystrophin by Company

3.1 Global Dystrophin Breakdown Data by Company

3.1.1 Global Dystrophin Annual Sales by Company (2020-2022)

3.1.2 Global Dystrophin Sales Market Share by Company (2020-2022)

3.2 Global Dystrophin Annual Revenue by Company (2020-2022)

3.2.1 Global Dystrophin Revenue by Company (2020-2022)

3.2.2 Global Dystrophin Revenue Market Share by Company (2020-2022)

3.3 Global Dystrophin Sale Price by Company

3.4 Key Manufacturers Dystrophin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Dystrophin Product Location Distribution

3.4.2 Players Dystrophin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Dystrophin by Geographic Region

4.1 World Historic Dystrophin Market Size by Geographic Region (2017-2022)

4.1.1 Global Dystrophin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Dystrophin Annual Revenue by Geographic Region

4.2 World Historic Dystrophin Market Size by Country/Region (2017-2022)

4.2.1 Global Dystrophin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Dystrophin Annual Revenue by Country/Region

4.3 Americas Dystrophin Sales Growth

4.4 APAC Dystrophin Sales Growth

4.5 Europe Dystrophin Sales Growth

4.6 Middle East & Africa Dystrophin Sales Growth

5 Americas

5.1 Americas Dystrophin Sales by Country

5.1.1 Americas Dystrophin Sales by Country (2017-2022)

5.1.2 Americas Dystrophin Revenue by Country (2017-2022)

5.2 Americas Dystrophin Sales by Type

5.3 Americas Dystrophin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dystrophin Sales by Region

6.1.1 APAC Dystrophin Sales by Region (2017-2022)

6.1.2 APAC Dystrophin Revenue by Region (2017-2022)

6.2 APAC Dystrophin Sales by Type

6.3 APAC Dystrophin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Dystrophin by Country

7.1.1 Europe Dystrophin Sales by Country (2017-2022)

7.1.2 Europe Dystrophin Revenue by Country (2017-2022)

7.2 Europe Dystrophin Sales by Type

7.3 Europe Dystrophin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dystrophin by Country

8.1.1 Middle East & Africa Dystrophin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Dystrophin Revenue by Country (2017-2022)

8.2 Middle East & Africa Dystrophin Sales by Type

8.3 Middle East & Africa Dystrophin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Dystrophin

10.3 Manufacturing Process Analysis of Dystrophin

10.4 Industry Chain Structure of Dystrophin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Dystrophin Distributors

11.3 Dystrophin Customer

12 World Forecast Review for Dystrophin by Geographic Region

12.1 Global Dystrophin Market Size Forecast by Region

12.1.1 Global Dystrophin Forecast by Region (2023-2028)

12.1.2 Global Dystrophin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Dystrophin Forecast by Type

12.7 Global Dystrophin Forecast by Application

13 Key Players Analysis

13.1 Asklepios BioPharmaceutical Inc

13.1.1 Asklepios BioPharmaceutical Inc Company Information

13.1.2 Asklepios BioPharmaceutical Inc Dystrophin Product Offered

13.1.3 Asklepios BioPharmaceutical Inc Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Asklepios BioPharmaceutical Inc Main Business Overview

13.1.5 Asklepios BioPharmaceutical Inc Latest Developments

13.2 BioMarin Pharmaceutical Inc

13.2.1 BioMarin Pharmaceutical Inc Company Information

13.2.2 BioMarin Pharmaceutical Inc Dystrophin Product Offered

13.2.3 BioMarin Pharmaceutical Inc Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BioMarin Pharmaceutical Inc Main Business Overview

13.2.5 BioMarin Pharmaceutical Inc Latest Developments

13.3 Daiichi Sankyo Company Ltd

13.3.1 Daiichi Sankyo Company Ltd Company Information

13.3.2 Daiichi Sankyo Company Ltd Dystrophin Product Offered

13.3.3 Daiichi Sankyo Company Ltd Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Daiichi Sankyo Company Ltd Main Business Overview

13.3.5 Daiichi Sankyo Company Ltd Latest Developments

13.4 Editas Medicine Inc

13.4.1 Editas Medicine Inc Company Information

13.4.2 Editas Medicine Inc Dystrophin Product Offered

13.4.3 Editas Medicine Inc Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Editas Medicine Inc Main Business Overview

13.4.5 Editas Medicine Inc Latest Developments

13.5 Genethon SA

13.5.1 Genethon SA Company Information

13.5.2 Genethon SA Dystrophin Product Offered

13.5.3 Genethon SA Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Genethon SA Main Business Overview

13.5.5 Genethon SA Latest Developments

13.6 Nippon Shinyaku Co Ltd

13.6.1 Nippon Shinyaku Co Ltd Company Information

13.6.2 Nippon Shinyaku Co Ltd Dystrophin Product Offered

13.6.3 Nippon Shinyaku Co Ltd Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Nippon Shinyaku Co Ltd Main Business Overview

13.6.5 Nippon Shinyaku Co Ltd Latest Developments

13.7 Pfizer Inc

13.7.1 Pfizer Inc Company Information

13.7.2 Pfizer Inc Dystrophin Product Offered

13.7.3 Pfizer Inc Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer Inc Main Business Overview

13.7.5 Pfizer Inc Latest Developments

13.8 Sarepta Therapeutics Inc

13.8.1 Sarepta Therapeutics Inc Company Information

13.8.2 Sarepta Therapeutics Inc Dystrophin Product Offered

13.8.3 Sarepta Therapeutics Inc Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sarepta Therapeutics Inc Main Business Overview

13.8.5 Sarepta Therapeutics Inc Latest Developments

13.9 WAVE Life Sciences Ltd

13.9.1 WAVE Life Sciences Ltd Company Information

13.9.2 WAVE Life Sciences Ltd Dystrophin Product Offered

13.9.3 WAVE Life Sciences Ltd Dystrophin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 WAVE Life Sciences Ltd Main Business Overview

13.9.5 WAVE Life Sciences Ltd Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Dystrophin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Dystrophin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of DS-5141

Table 4. Major Players of Biostrophin

Table 5. Major Players of BMBD-001

Table 6. Major Players of NS-065

Table 7. Major Players of Others

Table 8. Global Dystrophin Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Dystrophin Sales Market Share by Type (2017-2022)

Table 10. Global Dystrophin Revenue by Type (2017-2022) & ($ million)

Table 11. Global Dystrophin Revenue Market Share by Type (2017-2022)

Table 12. Global Dystrophin Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Dystrophin Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Dystrophin Sales Market Share by Application (2017-2022)

Table 15. Global Dystrophin Revenue by Application (2017-2022)

Table 16. Global Dystrophin Revenue Market Share by Application (2017-2022)

Table 17. Global Dystrophin Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Dystrophin Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Dystrophin Sales Market Share by Company (2020-2022)

Table 20. Global Dystrophin Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Dystrophin Revenue Market Share by Company (2020-2022)

Table 22. Global Dystrophin Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Dystrophin Producing Area Distribution and Sales Area

Table 24. Players Dystrophin Products Offered

Table 25. Dystrophin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Dystrophin Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Dystrophin Sales Market Share Geographic Region (2017-2022)

Table 30. Global Dystrophin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Dystrophin Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Dystrophin Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Dystrophin Sales Market Share by Country/Region (2017-2022)

Table 34. Global Dystrophin Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Dystrophin Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Dystrophin Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Dystrophin Sales Market Share by Country (2017-2022)

Table 38. Americas Dystrophin Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Dystrophin Revenue Market Share by Country (2017-2022)

Table 40. Americas Dystrophin Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Dystrophin Sales Market Share by Type (2017-2022)

Table 42. Americas Dystrophin Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Dystrophin Sales Market Share by Application (2017-2022)

Table 44. APAC Dystrophin Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Dystrophin Sales Market Share by Region (2017-2022)

Table 46. APAC Dystrophin Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Dystrophin Revenue Market Share by Region (2017-2022)

Table 48. APAC Dystrophin Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Dystrophin Sales Market Share by Type (2017-2022)

Table 50. APAC Dystrophin Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Dystrophin Sales Market Share by Application (2017-2022)

Table 52. Europe Dystrophin Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Dystrophin Sales Market Share by Country (2017-2022)

Table 54. Europe Dystrophin Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Dystrophin Revenue Market Share by Country (2017-2022)

Table 56. Europe Dystrophin Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Dystrophin Sales Market Share by Type (2017-2022)

Table 58. Europe Dystrophin Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Dystrophin Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Dystrophin Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Dystrophin Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Dystrophin Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Dystrophin Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Dystrophin Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Dystrophin Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Dystrophin Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Dystrophin Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Dystrophin

Table 69. Key Market Challenges & Risks of Dystrophin

Table 70. Key Industry Trends of Dystrophin

Table 71. Dystrophin Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Dystrophin Distributors List

Table 74. Dystrophin Customer List

Table 75. Global Dystrophin Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Dystrophin Sales Market Forecast by Region

Table 77. Global Dystrophin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Dystrophin Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Dystrophin Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Dystrophin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Dystrophin Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Dystrophin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Dystrophin Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Dystrophin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Dystrophin Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Dystrophin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Dystrophin Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Dystrophin Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Dystrophin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Dystrophin Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Dystrophin Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Dystrophin Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Dystrophin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Dystrophin Revenue Market Share Forecast by Application (2023-2028)

Table 95. Asklepios BioPharmaceutical Inc Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 96. Asklepios BioPharmaceutical Inc Dystrophin Product Offered

Table 97. Asklepios BioPharmaceutical Inc Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Asklepios BioPharmaceutical Inc Main Business

Table 99. Asklepios BioPharmaceutical Inc Latest Developments

Table 100. BioMarin Pharmaceutical Inc Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 101. BioMarin Pharmaceutical Inc Dystrophin Product Offered

Table 102. BioMarin Pharmaceutical Inc Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. BioMarin Pharmaceutical Inc Main Business

Table 104. BioMarin Pharmaceutical Inc Latest Developments

Table 105. Daiichi Sankyo Company Ltd Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 106. Daiichi Sankyo Company Ltd Dystrophin Product Offered

Table 107. Daiichi Sankyo Company Ltd Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Daiichi Sankyo Company Ltd Main Business

Table 109. Daiichi Sankyo Company Ltd Latest Developments

Table 110. Editas Medicine Inc Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 111. Editas Medicine Inc Dystrophin Product Offered

Table 112. Editas Medicine Inc Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Editas Medicine Inc Main Business

Table 114. Editas Medicine Inc Latest Developments

Table 115. Genethon SA Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 116. Genethon SA Dystrophin Product Offered

Table 117. Genethon SA Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Genethon SA Main Business

Table 119. Genethon SA Latest Developments

Table 120. Nippon Shinyaku Co Ltd Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 121. Nippon Shinyaku Co Ltd Dystrophin Product Offered

Table 122. Nippon Shinyaku Co Ltd Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Nippon Shinyaku Co Ltd Main Business

Table 124. Nippon Shinyaku Co Ltd Latest Developments

Table 125. Pfizer Inc Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 126. Pfizer Inc Dystrophin Product Offered

Table 127. Pfizer Inc Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Pfizer Inc Main Business

Table 129. Pfizer Inc Latest Developments

Table 130. Sarepta Therapeutics Inc Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 131. Sarepta Therapeutics Inc Dystrophin Product Offered

Table 132. Sarepta Therapeutics Inc Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Sarepta Therapeutics Inc Main Business

Table 134. Sarepta Therapeutics Inc Latest Developments

Table 135. WAVE Life Sciences Ltd Basic Information, Dystrophin Manufacturing Base, Sales Area and Its Competitors

Table 136. WAVE Life Sciences Ltd Dystrophin Product Offered

Table 137. WAVE Life Sciences Ltd Dystrophin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. WAVE Life Sciences Ltd Main Business

Table 139. WAVE Life Sciences Ltd Latest Developments

List of Figures

Figure 1. Picture of Dystrophin

Figure 2. Dystrophin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Dystrophin Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Dystrophin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Dystrophin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of DS-5141

Figure 10. Product Picture of Biostrophin

Figure 11. Product Picture of BMBD-001

Figure 12. Product Picture of NS-065

Figure 13. Product Picture of Others

Figure 14. Global Dystrophin Sales Market Share by Type in 2021

Figure 15. Global Dystrophin Revenue Market Share by Type (2017-2022)

Figure 16. Dystrophin Consumed in Genetic Disorders

Figure 17. Global Dystrophin Market: Genetic Disorders (2017-2022) & (K Pcs)

Figure 18. Dystrophin Consumed in Musculoskeletal Disorders

Figure 19. Global Dystrophin Market: Musculoskeletal Disorders (2017-2022) & (K Pcs)

Figure 20. Dystrophin Consumed in Others

Figure 21. Global Dystrophin Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Dystrophin Sales Market Share by Application (2017-2022)

Figure 23. Global Dystrophin Revenue Market Share by Application in 2021

Figure 24. Dystrophin Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Dystrophin Revenue Market Share by Company in 2021

Figure 26. Global Dystrophin Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Dystrophin Revenue Market Share by Geographic Region in 2021

Figure 28. Global Dystrophin Sales Market Share by Region (2017-2022)

Figure 29. Global Dystrophin Revenue Market Share by Country/Region in 2021

Figure 30. Americas Dystrophin Sales 2017-2022 (K Pcs)

Figure 31. Americas Dystrophin Revenue 2017-2022 ($ Millions)

Figure 32. APAC Dystrophin Sales 2017-2022 (K Pcs)

Figure 33. APAC Dystrophin Revenue 2017-2022 ($ Millions)

Figure 34. Europe Dystrophin Sales 2017-2022 (K Pcs)

Figure 35. Europe Dystrophin Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Dystrophin Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Dystrophin Revenue 2017-2022 ($ Millions)

Figure 38. Americas Dystrophin Sales Market Share by Country in 2021

Figure 39. Americas Dystrophin Revenue Market Share by Country in 2021

Figure 40. United States Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Dystrophin Sales Market Share by Region in 2021

Figure 45. APAC Dystrophin Revenue Market Share by Regions in 2021

Figure 46. China Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Dystrophin Sales Market Share by Country in 2021

Figure 53. Europe Dystrophin Revenue Market Share by Country in 2021

Figure 54. Germany Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Dystrophin Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Dystrophin Revenue Market Share by Country in 2021

Figure 61. Egypt Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Dystrophin Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Dystrophin in 2021

Figure 67. Manufacturing Process Analysis of Dystrophin

Figure 68. Industry Chain Structure of Dystrophin

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390